85 related articles for article (PubMed ID: 21469230)
1. "Double-click" protocol for synthesis of heterobifunctional multivalent ligands: toward a focused library of specific norovirus inhibitors.
Guiard J; Fiege B; Kitov PI; Peters T; Bundle DR
Chemistry; 2011 Jun; 17(27):7438-41. PubMed ID: 21469230
[No Abstract] [Full Text] [Related]
2. Targeting norovirus infection-multivalent entry inhibitor design based on NMR experiments.
Rademacher C; Guiard J; Kitov PI; Fiege B; Dalton KP; Parra F; Bundle DR; Peters T
Chemistry; 2011 Jun; 17(27):7442-53. PubMed ID: 21567493
[TBL] [Abstract][Full Text] [Related]
3. 2-Substituted-4,5-dihydroxypyrimidine-6-carboxamide antiviral targeted libraries.
Boyd VA; Mason J; Hanumesh P; Price J; Russell CJ; Webb TR
J Comb Chem; 2009; 11(6):1100-4. PubMed ID: 19754047
[TBL] [Abstract][Full Text] [Related]
4. Trapping norovirus by glycosylated hydrogels: a potential oral antiviral drug.
Zhang Y; Yao Q; Xia C; Jiang X; Wang PG
ChemMedChem; 2006 Dec; 1(12):1361-6. PubMed ID: 17042040
[No Abstract] [Full Text] [Related]
5. Rational design and synthesis of 2,2-bisheterocycle tandem derivatives as non-nucleoside hepatitis B virus inhibitors.
Chen HJ; Wang WL; Wang GF; Shi LP; Gu M; Ren YD; Hou LF; He PL; Zhu FH; Zhong XG; Tang W; Zuo JP; Nan FJ
ChemMedChem; 2008 Sep; 3(9):1316-21. PubMed ID: 18663717
[No Abstract] [Full Text] [Related]
6. Naphthoxazepine inhibitors of HIV-1 integrase: synthesis and biological evaluation.
Garofalo A; Grande F; Brizzi A; Aiello F; Dayam R; Neamati N
ChemMedChem; 2008 Jun; 3(6):986-90. PubMed ID: 18383063
[TBL] [Abstract][Full Text] [Related]
7. Discovery and Synthesis of Heterocyclic Carboxamide Derivatives as Potent Anti-norovirus Agents.
Ohba M; Oka T; Ando T; Arahata S; Ikegaya A; Takagi H; Ogo N; Owada K; Kawamori F; Wang Q; Saif LJ; Asai A
Chem Pharm Bull (Tokyo); 2016; 64(5):465-75. PubMed ID: 27150478
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiviral activity of an imidazo[1,2-a]pyrrolo[2,3-c]pyridine series against the bovine viral diarrhea virus.
Chezal JM; Paeshuyse J; Gaumet V; Canitrot D; Maisonial A; Lartigue C; Gueiffier A; Moreau E; Teulade JC; Chavignon O; Neyts J
Eur J Med Chem; 2010 May; 45(5):2044-7. PubMed ID: 20149501
[TBL] [Abstract][Full Text] [Related]
9. (E)-2-styrylchromones as potential anti-norovirus agents.
Rocha-Pereira J; Cunha R; Pinto DC; Silva AM; Nascimento MS
Bioorg Med Chem; 2010 Jun; 18(12):4195-201. PubMed ID: 20554208
[TBL] [Abstract][Full Text] [Related]
10. Delivery of suramin as an antiviral agent through liposomal systems.
Mastrangelo E; Mazzitelli S; Fabbri J; Rohayem J; Ruokolainen J; Nykänen A; Milani M; Pezzullo M; Nastruzzi C; Bolognesi M
ChemMedChem; 2014 May; 9(5):933-9. PubMed ID: 24616282
[TBL] [Abstract][Full Text] [Related]
11. Discovery of bioavailable 4,4-disubstituted piperidines as potent ligands of the chemokine receptor 5 and inhibitors of the human immunodeficiency virus-1.
Kazmierski WM; Aquino C; Chauder BA; Deanda F; Ferris R; Jones-Hertzog DK; Kenakin T; Koble CS; Watson C; Wheelan P; Yang H; Youngman M
J Med Chem; 2008 Oct; 51(20):6538-46. PubMed ID: 18811134
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 2'-fluoro and 2',4'-dimethyl pyrimidine C-nucleoside analogues as potential anti-HCV agents.
Liu LJ; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2010 Mar; 29(3):216-27. PubMed ID: 20408052
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiviral activity of new acrylamide derivatives containing 1,2,3-thiadiazole as inhibitors of hepatitis B virus replication.
Dong WL; Liu ZX; Liu XH; Li ZM; Zhao WG
Eur J Med Chem; 2010 May; 45(5):1919-26. PubMed ID: 20149495
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of 7H-benzo[4,5]indolo[2,3-b]-quinoxaline derivatives.
Shibinskaya MO; Karpenko AS; Lyakhov SA; Andronati SA; Zholobak NM; Spivak NY; Samochina NA; Shafran LM; Zubritsky MJ; Galat VF
Eur J Med Chem; 2011 Feb; 46(2):794-8. PubMed ID: 21172726
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of phosphonated dihydroisoxazole nucleosides.
Romeo G; Iannazzo D; Piperno A; Romeo R; Saglimbeni M; Chiacchio MA; Balestrieri E; Macchi B; Mastino A
Bioorg Med Chem; 2006 Jun; 14(11):3818-24. PubMed ID: 16480883
[TBL] [Abstract][Full Text] [Related]
16. Structure-Guided Optimization of Dipeptidyl Inhibitors of Norovirus 3CL Protease.
Rathnayake AD; Kim Y; Dampalla CS; Nguyen HN; Jesri AM; Kashipathy MM; Lushington GH; Battaile KP; Lovell S; Chang KO; Groutas WC
J Med Chem; 2020 Oct; 63(20):11945-11963. PubMed ID: 32945669
[TBL] [Abstract][Full Text] [Related]
17. Substituted 5-benzyl-2-phenyl-5H-imidazo[4,5-c]pyridines: a new class of pestivirus inhibitors.
Puerstinger G; Paeshuyse J; Herdewijn P; Rozenski J; De Clercq E; Neyts J
Bioorg Med Chem Lett; 2006 Oct; 16(20):5345-9. PubMed ID: 16901692
[TBL] [Abstract][Full Text] [Related]
18. Development of antiviral fusion inhibitors: short modified peptides derived from the transmembrane glycoprotein of feline immunodeficiency virus.
D'Ursi AM; Giannecchini S; Esposito C; Alcaro MC; Sichi O; Armenante MR; Carotenuto A; Papini AM; Bendinelli M; Rovero P
Chembiochem; 2006 May; 7(5):774-9. PubMed ID: 16566046
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of abietic acid derivatives.
González MA; Correa-Royero J; Agudelo L; Mesa A; Betancur-Galvis L
Eur J Med Chem; 2009 Jun; 44(6):2468-72. PubMed ID: 19217699
[TBL] [Abstract][Full Text] [Related]
20. Cyclosulfamide-based derivatives as inhibitors of noroviruses.
Dou D; Mandadapu SR; Alliston KR; Kim Y; Chang KO; Groutas WC
Eur J Med Chem; 2012 Jan; 47(1):59-64. PubMed ID: 22063754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
